Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Marchex (MCHX) over the last 16 years, with Q3 2025 value amounting to $270000.0.

  • Marchex's Gains from Sales and Divestitures fell 2458.1% to $270000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $270000.0, marking a year-over-year decrease of 2458.1%. This contributed to the annual value of $361000.0 for FY2024, which is 3252.34% down from last year.
  • Marchex's Gains from Sales and Divestitures amounted to $270000.0 in Q3 2025, which was down 2458.1% from $233000.0 recorded in Q2 2025.
  • In the past 5 years, Marchex's Gains from Sales and Divestitures registered a high of $535000.0 during Q4 2023, and its lowest value of $71.0 during Q1 2021.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $104000.0 (2024), whereas its average is $160850.7.
  • As far as peak fluctuations go, Marchex's Gains from Sales and Divestitures tumbled by 4904.76% in 2021, and later soared by 7107296.22% in 2024.
  • Marchex's Gains from Sales and Divestitures (Quarter) stood at $476000.0 in 2021, then increased by 3.36% to $492000.0 in 2022, then increased by 8.74% to $535000.0 in 2023, then crashed by 32.52% to $361000.0 in 2024, then fell by 25.21% to $270000.0 in 2025.
  • Its Gains from Sales and Divestitures was $270000.0 in Q3 2025, compared to $233000.0 in Q2 2025 and $118000.0 in Q1 2025.